A combination treatment may improve survival in patients with both pulmonary hypertension and pulmonary fibrosis, a study ...

Reducing the levels of the protein NEK2 in the pulmonary arteries may reverse vascular remodeling in PAH, a rat study showed.

Synhale Therapeutics has acquired the rights to the experimental therapy telaglenastat (CB-839), which has previously been tested as a potential cancer therapy. The company is planning to launch a ...

Hospital rounds are usually morning visits from a patient’s healthcare team to review their condition, treatment plan, and progress. The patient is examined, vitals are checked, and additional tests ...